PITX2 gene is a prognostic marker for progesterone receptor‐positive patients, and it is closely associated with poor survival and distant metastasis of breast tumours. If PITX 2 gene is methylated, it can be considered low risk of distant metastasis recurrences and need not adjuvant chemotherapy. Here, PITX2 is linked to breast neoplasm.